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Synopsis:

A use of polypectomy techniques and the odds of serious gastrointestinal adverse events vary by
endoscopist specialty (i.e., primary care, surgery, and gastroenterology) and for low-, medium-,
and high-volume providers. Simple cold biopsy forceps appeared to be safe for the use by all
types of endoscopists. For primary and single hot biopsy forceps/ablation or snare polypectomy,
high-volume endoscopists may be preferred providers; and gastroenterologists or surgeons may
be best fit to provide complex polypectomy procedures.
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Abstract:
Background: A use of polypectomy techniques by endoscopist specialty (primary care, surgery,
and gastroenterology) and experience (volume), and associations with serious gastrointestinal
adverse events, were examined.
Methods: A retrospective follow-up study with ambulatory surgery and hospital discharge
datasets from Florida, 1999-2001, was used. Thirty-day hospitalizations due to colonic
perforations and gastrointestinal bleeding were investigated for 323,585 patients.
Results: Primary care endoscopists and surgeons used hot biopsy forceps/ablation, while
gastroenterologists provided snare polypectomy or complex colonoscopy. Low-volume
endoscopists were more likely to use simpler rather than complex procedures. For hot
forceps/ablation and snare polypectomy, low- and medium-volume endoscopists reported higher
odds of adverse events. For complex colonoscopy, higher odds of adverse events were reported
for primary care endoscopists (1.74 [95%CI, 1.18 to 2.56]) relative to gastroenterologists
Conclusions: Endoscopists regardless of specialty and experience can safely use cold biopsy
forceps. For hot biopsy and snare polypectomy, low volume, but not specialty, contributed to
increased odds of adverse events. For complex colonoscopy, primary care specialty, but not low
volume, added to the odds of adverse events. Comparable outcomes were reported for surgeons
and gastroenterologists. Cross-training and continuing medical education of primary care
endoscopists in high-volume endoscopy settings are recommended for complex colonoscopy
procedures.

3

Background (Word Count – 3,038)
Colorectal cancer (CRC) remains one of the most common cancers and causes of cancer
mortality in the United States [1,2]. The expenditures for treatment of CRC were approximately
$8.4 billion in 2004 [3]. CRC is preventable through removal of premalignant polyps, which
makes colonic polypectomy a preferred method of CRC prevention [2]. The number of
colonoscopies is approximately14 million per year [4]. The demand for colonoscopy is expected
to grow due primarily to the aging population in the U.S [4]. Advances in technology and
inclusion of gastrointestinal (GI) endoscopy in training of primary care physicians and surgeons
allowed generalists to provide colonoscopy procedures that used to be in the realm of
gastroenterologist care [5]. A shortfall of up to 1,550 gastroenterologists is estimated by 2020
[6] and as such, the role of primary care physicians and surgeons in providing CRC prevention
services including colonoscopy is likely to remain unchanged over time. In the era of health
reform with its focus on improvement of quality of care, cost containment, and population
health, both specialists and generalists need to demonstrate the value and quality of care [7],
particularly when it is relevant to cancer prevention.
Previous research has generally favored specialists over generalists for quality of care
across various conditions [8]. Research findings on the endoscopist specialty, quality of
colonoscopy, and patient outcomes were mixed [7]. No difference among gastroenterologists
and family physicians in the proportion of cecal intubation and polyp detection rates for
colonoscopy patients was reported [7]. One study favored gastroenterology over surgical
trainees for colonoscopy completion rates and adenoma detection rates [9]. The risk of postcolonoscopy CRC was higher for primary care endoscopists in comparison with surgeons and
gastroenterologists suggesting that primary care endoscopists were more likely to miss or leave
4

residual polyps during colonoscopy [10]. Endoscopist experience that was operationalized as an
annual volume of procedures may affect patient outcomes, as previous research favored highvolume over low-volume endoscopists in terms of the risks of adverse gastrointestinal (GI)
events due to colonoscopy [11,12].
Screening and diagnostic colonoscopy procedures are relatively safe; however, outpatient
polypectomy is associated with a nine-fold increase in risks of serious adverse events, such as
colonic perforations and GI bleeding that require inpatient admission, in comparison with
colonoscopy without polypectomy [13]. Prior research also discovered that as complexity of
polypectomy increased, a higher risk of serious GI adverse events was reported [12]. While
gastroenterologists’ use of polypectomy techniques is highly variable for polyps of similar sizes
[14], a preferred polypectomy technique is not yet identified [12-15]. Primary care endoscopists
tend to use less complex GI procedures and select healthier patients with lower severity of illness
and less comorbidities [5]. As such, the risks of serious GI adverse events due to polypectomy
may depend on the endoscopist specialty and experience [9,12], a specific polypectomy
technique [12], clinical factors (e.g., severity of illness, polyp size and type) [16], and patient
characteristics (e.g., age, comorbidities) [17].
With a growing emphasis on quality and efficiency of colonoscopy for CRC prevention,
the debate about the use of polypectomy and the value of endoscopist specialty and experience
may intensify. However, a lack of data on a preferential use of specific polypectomy techniques
by endoscopist specialty and experience, as well as its impact on the rates of serious GI adverse
events, leaves a substantial gap in the literature. In addition, previous research on the efficiency
and effectiveness of care provided by generalists versus specialists was criticized for
methodological shortcomings such as failures to account for confounding factors of physician
5

experience, practice settings, severity of illness and comorbidity in the patient populations [8].
We study a preferential use of polypectomy techniques by endoscopist specialty (primary
care, surgery, and gastroenterology) and experience (volume), and their associations with serious
gastrointestinal adverse events. This study accounts for differences in practice settings and uses
a validated method of risk adjustment for both severity of illness and comorbid diagnoses. This
study uses a large, encounter-level, and all payer dataset with patient and physician identifiers for
all Florida ambulatory surgery centers (ASC), hospital-based outpatient departments (HOPD),
and hospitals to identify hospitalizations for serious GI adverse events due to colonic
perforations and GI bleeding within 30 days after colonoscopy. These data covered the entire
population of Florida that was treated in the outpatient surgery setting. Another unique feature
of these databases is that they included operating physicians’ identification numbers and
specialty codes important for construction of key endoscopist measures for the period 1999 –
2001. Even though the study uses historic data, it provides an important baseline research, as it
is the first study investigating associations among the main polypectomy techniques that are
currently in use and endoscopist specialty, experience, and patient outcomes. As such, the study
findings are useful for future research and policy-making on polypectomy guidelines, postgraduate and continuing medical education in endoscopy, and CRC prevention.
Methods
Data Sources:
Ambulatory surgery and inpatient hospital discharge datasets were obtained from the
Florida Agency for Health Care Administration for 1999 through 2001. Both datasets were at the
encounter-level and included unique patient identifiers, primary and secondary diagnoses as
classified by the International Classification of Diseases, Ninth Revision, Clinical Modification
6

(ICD-9-CM), primary and secondary procedure codes based on Current Procedural Terminology
(CPT), payer types, facility types, dates of outpatient procedures and hospitalizations, and patient
demographic characteristics. Polypectomy procedures were linked to subsequent
hospitalizations to identify all hospital admissions for serious GI adverse events within 30 days.
Figure 1 describes how the analytical sample of 323,585 polypectomy procedures provided by
860 endoscopists was derived for 1999-2001 as the unique (and consistent over time) physician
identification numbers (UPIN) and the CMS physician specialty codes were available only for
this period.

Figure 1. Description of Analytical Sample

7

Dependent Variables
Polypectomy Procedures:
Four polypectomy categories were constructed using the CPT codes [18]. Cold biopsy
forceps were identified via primary CPT 45380 code for single or multiple biopsies and defined
as the simple polypectomy [18]. Two categories of polypectomy techniques were constructed
using primary CPT codes and identified as single polypectomy types: (1) hot biopsy forceps or
bipolar cautery (CPT 45384) and ablation of lesion(s) not amendable to removal by hot biopsy
forceps, bipolar cautery, or snare techniques (CPT 45383), combined into one category; and (2)
snare polypectomy (CPT 45385) [18]. The complex colonoscopy was where multiple
colonoscopy procedures were performed, and primary and secondary CPT codes with any
combination of procedures with cautery, control of bleeding, injections, and/or tattooing (CPT
45380, 45381, 45382, 45383, 45384, and/or 45385) were billed during the same session [18]. A
use of these techniques was highly variable for removing polyps of similar sizes [14].
Endoscopists currently use these main polypectomy techniques [14] that are also identifiable in
administrative databases [18].

Serious Adverse Events:
The primary patient outcome was a cumulative measure of hospitalizations due to colonic
perforation and/or GI bleeding within 30 days of a polypectomy that is procedure specific [16]
and potentially reflective of endoscopist skills [11-12]. Primary diagnosis codes in the inpatient
hospital discharge dataset were used to identify colonic perforations [ICD-9-CM: 569.83, 998.2],
GI bleeding [ICD-9-CM: 578.1, 578.9, 998.1], acute postheomorrhagic anemia [ICD-9-CM:
285.1], and blood transfusion [ICD-9-CM: 280-284.9, 285.2-285.9, 99.03, 99.04].
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Key Explanatory Variables
Endoscopist Specialty:
Endoscopist specialty categories were defined via the CMS specialty codes as: (1)
primary care (i.e., family practice, geriatric medicine, internal medicine, general practice,
obstetrics/gynecology, or preventive medicine), (2) surgery (i.e., thoracic surgery; surgical
oncology, vascular surgery, general surgery, or colorectal surgery), and (3) gastroenterology.

Endoscopist Polypectomy Volume:
The annual polypectomy volume for each endoscopist was calculated as the total number
of primary polypectomy procedures in each year of the study. Physicians were assigned to low
(less than 150 cases per year), medium (150-299 cases per year), or high (more than or equal to
300 cases per year) volume categories based on annual volume of all polypectomy procedures.
Providers’ volume was allowed to vary from year to year. The annual volume is often use as a
measure of provider experience [19].

Endoscopist Polypectomy Rate and Repeat Endoscopy:
A polypectomy rate (PR) for each endoscopist was calculated as a proportion of snare
polypectomy, hot biopsy, and cold biopsy procedures that had the ICD-9 code of 211.3 for polyp
detection to all diagnostic and polypectomy colonoscopies for the study period (1999-2001) [20].
We calculated the PR separately for each physician identifier and calendar year on a sample
(n=560,119) before exclusion of simple (i.e., diagnostic) procedures (Figure 1). The PR
calculated form administrative claims data are validated against adenoma detection rates (ADR)
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derived from endoscopy reports [20]. The PR is an accurate surrogate for the ADR [20]. A PR of
35% is needed to achieve a recommended ADR benchmark of 20% [20]. We included the PR as
a covariate reflecting experience of endoscopists in detecting adenomas.
Following the surveillance guidelines [21], a measure of repeat endoscopy was
constructed as an indicator variable when any type of colonoscopy procedures was provided to
the same patient within 12 months of an initial polypectomy. The measure of repeat endoscopy
was used as a covariate in multivariate logistic regression models to account for removal of large
sessile adenomas (that were likely removed piecemeal) at a shorter interval and required
individualized surveillance of patients by experienced endoscopists [21].

Control Variables:
A dichotomous variable representing facility type was included to identify facility types
as ASC or HOPD, where the majority of polypectomy procedures usually take place. Patient age
was categorized as: 19 – 49, 50 – 64, 65 – 74, 75 – 84, and > 85 years old. Race/ethnicity was
specified as: white, Hispanic, black or African American, or other (including unknowns).
Gender was included as a binary variable. Health insurance types were categorized as Medicare,
Medicare HMO, Medicaid, Medicaid HMO, commercial Indemnity, commercial Health
Maintenance Organizations (HMO), commercial Preferred Provider Organizations (PPO), selfpay or charity, and other. Diagnostic cost groups/hierarchical condition categories (DCG/HCC),
which used all available ICD-9-CM diagnostic codes to categorize patients, were used to
incorporate all comorbid conditions and indicate a greater severity of illness among patients with
higher risk scores [22-24]. Finally, unobserved changes over time common for both ASCs and
HOPDs (e.g., changes in practice guidelines, new policy recommendations) were controlled by
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including a set of dummy variables for each year between 1999 and 2001.
Statistical analysis:
Polypectomy procedures, provider, and patient characteristics were examined by
endoscopist specialty using univariate tests. Unadjusted rates for serious GI adverse events were
calculated by dividing the total numbers of adverse events by the total number of procedures for
specific polypectomy types by endoscopist specialty. Wald tests of linear restrictions were used
for descriptive analyses.
Multivariate logistic regression models were used to predict the preferential use of
polypectomy procedures (with each polypectomy category as a dependent variable) for
endoscopists specialized in primary care, surgery, or gastroenterology (referent) and those in
low-, medium-, and high-volume (referent) categories. In a separate set of multivariate analyses
with serious GI adverse events as the dependent variable, polypectomy categories were used for
stratification, to predict the adjusted odds of adverse events for each endoscopist specialty and
volume categories as described above.
Odds ratios were estimated to evaluate the magnitude and direction of the effect for the
key parameters of interest, after adjusting for the contributions of other covariates: 2 facility
types with HOPD as the reference; 5 patient age categories with 19 – 49 as the reference; 4
race/ethnicity categories with white as the reference; gender with male as the reference; 4 health
insurance types with Medicare as the reference; patient severity of illness measured as
continuous risk scores; and variables for each year with 1999 as the reference.
As the univariate tests were exploratory and meant to highlight differences, their
significant results were not subjected to any corrections for multiple testing. The results from the
multivariate analyses are most definitive. There are no corrections for multiple testing to their
11

results, as these findings are to be taken as suggestive only due to the source and nature of the
data, with their inherent limitations. We tested for multicollinearity, correlations, and interactions
between covariates. Statistical significance was determined at p < 0.05. The university
institutional review board approved the study.
All data were collected in 2006, and the current analysis was conducted in 2013. There is
a time lag of several years for organizing claims data into analytical files and making them
available to researchers. We obtained these data from the Florida Agency for Health Care
Administration to study comparative effectiveness of ASCs and HOPDs. Once that analysis was
complete, the research team turned to other topics of interest including the one presented in this
paper. When using claims data, a lag of several years is not unusual.

Results
Descriptive analyses:
Gastroenterologists represented the majority of endoscopists (n=528, 61.4%) (Table 1).
There were 153 (17.8%) primary care providers of polypectomies, specializing in internal
medicine (n=107, 69.9%), family medicine (n=33, 21.6%), general practice (n=8, 5.2%) and
obstetrics/gynecology (n=5, 3.3%). Surgeons (n=179, 20.8%) specializing in general surgery
(n=137, 76.5%), colon/rectal surgery (n=37, 20.7%), and other types of surgery (n=5. 2.8%).
Less than 1% of polypectomy procedures resulted in serious GI adverse events. Adverse events
by specialty categories were not statistically different for primary care (0.43%), surgery (0.39%),
and gastroenterology (0.35%). Primary care endoscopists provided higher proportions of cold
biopsy procedures than surgeons and gastroenterologists. Surgeons used more of hot
biopsy/ablation procedures in comparison with primary care physicians and gastroenterologists.
12

Gastroenterologists primarily performed snare polypectomy and complex colonoscopy
procedures. Surgeons performed more polypectomy procedures in a hospital-based setting rather
than in ASCs. Gastroenterologists performed a higher mean volume of polypectomy procedures
(n=321) in comparison with primary care endoscopists (n=200) and surgeons (n=180). A
polypectomy rate was lower for surgeons (0.33) than for primary care endoscopists (0.39) and
gastroenterologists (0.38). Table 1 also reports patient characteristics by endoscopist specialties
that were primarily similar across endoscopist specialties. Primary care endoscopists treated
higher proportions of minorities and patients covered by Medicare HMO, Medicaid, selfpay/charity, and other payers. Different types of endoscopists provided polypectomies to
patients with comparable severity of illness (Table 1).
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Table 1. Serious GI Adverse Events, Procedure, Provider, and Patient Characteristics by
Endoscopist Specialty
Primary Care

Surgery

Gastroenterology

Total

P-value

Number of endoscopists (%)

153 (17.79)

179 (20.81)

528 (61.4)

860 (100)

***

Serious GI adverse events, n (%)
Unadjusted rate of AE (%)
Polypectomy procedures (%)
Total number of procedures
Repeat endoscopy (%)

99 (8.43)
0.43
22,797 (7.05)
39,165 (6.70)
415 (1.82)

90 (7.67)
0.39
23,019 (7.11)
45,518 (8.13)
588 (2.55)

985 (83.90)
0.35
277,769 (85.84)
475,422 (84.88)
5,566 (2.00)

1,174 (100)
0.36
323,585 (100)
560,105 (100)
6,569 (2.03)

***

Polypectomy Procedures:
Cold biopsy forceps

5,728 (25.13)

3,723 (16.17)

63,700 (22.93)

73,151 (22.61)

***

Hot biopsy forceps/Ablation
Snare polypectomy

7,728 (33.90)
6,252 (27.42)

9950 (43.23)
5886 (25.57)

80,808 (29.09)
87,638 (31.55)

98,486 (30.44)
99,776 (30.83)

***
***

Complex Colonoscopy

3,089 (13.55)

3,460 (15.03)

45,623 (16.42)

52,172 (16.12)

***

Provider Characteristics:
Endoscopist Volume, mean (SD)

200 (154)

180 (163)

321 (238)

302 (233)

***

Volume Category, mean (SD)
< 150
150 - 299
> 300
Polypectomy rate, mean (SD)
ASCs, n (%)
HOPDs, n (%)

78 (44)
208 (40)
454 (104)
0.392 (0.23)
11,185 (49.06)
11,612 (50.94)

67 (40)
231 (42)
506 (114)
0.326 (0.21)
9,827 (42.69)
13,192 (57.31)

99 (37)
224 (42)
514 (256)
0.381 (0.16)
139,003 (50.04)
138,766 (49.96)

91 (41)
223 (42)
511 (249)
0.372 (0.19)
160,015 (49.45)
163,570 (50.55)

3,295 (14.45)
7,182 (31.50)
6,913 (30.32)
4,691 (20.58)
716 (3.14)

3,087 (13.41)
6,599 (28.67)
7,354 (31.95)
5,178 (22.49)
801 (3.48)

40,851 (14.71)
87,448 (31.48)
84,536 (30.43)
56,342 (20.28)
8,592 (3.09)

47,233 (14.60)
101,229 (31.28)
98,803 (30.53)
66,211 (20.46)
10,109 (3.12)

***
***
***
***
***

11,278 (49.47)
11,519 (50.53)

12,793 (55.58)
10,226 (44.42)

138,363 (49.81)
139,406 (50.19)

162,434 (50.2)
161,151 (49.8)

***

17,593 (77.17)
2,637 (11.57)
1,244 (5.46)
1,323 (5.80)

19,035 (82.69)
1,658 (7.20)
764 (3.32)
1,562 (6.79)

233,523 (84.07)
14,411 (5.19)
10,962 (3.95)
18,873 (6.79)

270,151 (83.49)
18,706 (5.78)
12,970 (4.01)
21,758 (6.72)

***
***
***
***

1.45 (0.7)

1.44 (0.67)

1.44 (0.69)

1.44 (0.69)

11,380 (49.92)
466 (2.04)
10,180 (44.65)
771 (3.38)

10,993 (47.76)
307 (1.33)
11,226 (48.77)
493 (2.14)

135,021 (48.61)
3,091 (1.11)
132,672 (47.76)
6,985 (2.51)

157,394 (48.64)
3,864 (1.19)
154,078 (47.62)
8,249 (2.55)

Patient Characteristics:
Age categories, years, n (%):
19 – 49
50 – 64
65 – 74
75 – 84
> 85
Gender, n (%):
Male
Female
Race, n (%):
White
Hispanic
Black/African American
Other/unknown
Severity of Illness:
Risk Score, mean (SD)
Insurance Types, n (%):
Medicare/ Medicare HMO
Medicaid/ Medicaid HMO
Indemnity/ Commercial
Self pay/Charity/Other

***
***
***

***

***
***

***
***
***
***

***: p<0.01
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Unadjusted rates of serious GI adverse events for all and specific polypectomy
procedures were calculated and increased with the rise in complexity of polypectomy procedures
for each endoscopist specialty (Table 2). The rate of increase in adverse events was the lowest
for gastroenterologists in comparison with both primary care providers and surgeons. Unadjusted
rates of serious adverse events were the highest for primary care endoscopists providing complex
colonoscopy.

Table 2. Unadjusted Rates of Serious GI Adverse Events per 1,000 Polypectomies by Procedure
Type and Endoscopist Specialty
All procedures
Cold biopsy forceps
Hot biopsy forceps/Ablation
Snare polypectomy
Complex Colonoscopy

Primary Care

Surgery

Gastroenterology

4.343 (3.531 - 5.285)
1.397 (0.603 - 2.750)
3.106 (1.991 - 4.617)
5.758 (4.036 - 7.963)
10.036 (6.829 - 14.215)

3.910 (3.145 - 4.804)
2.417 (1.106 - 4.584)
3.216 (2.201 - 4.537)
4.927 (3.302 - 7.068)
5.780 (3.534 - 8.913)

3.546 (3.328 - 3.774)
1.319 (1.052 - 1.632)
3.341 (2.955 - 3.764)
4.507 (4.075 - 4.973)
5.173 (4.535 - 5.875)

Multivariate Analyses:
Table 3 reports the likelihood of receiving each type of polypectomy by endoscopist
specialty and endoscopist polypectomy volume, controlling for other covariates. Compared to
gastroenterologists, the odds ratios for using cold biopsy forceps were significantly greater for
primary care endoscopists (1.12 [95%CI, 1.09 to 1.16]) and lower for surgeons (0.61 [95%CI,
0.59 to 0.63]). The odds ratios for using hot biopsy forceps/ablation were greater for primary
care providers (1.20 [95%CI, 1.17 to 1.24]) and surgeons (1.84 [95%CI, 1.79 to 1.90]) relative to
gastroenterologists. The odds for using snare polypectomy and complex colonoscopy procedures
were lower for non-gastroenterologists than for gastroenterologists (Table 3). Low-volume
endoscopists were more likely to use cold biopsy forceps, and hot biopsy forceps/ablation - and
were less likely to use snare polypectomy and complex colonoscopy procedures than high15

volume providers (Table 3). Polypectomy rates increased for endoscopists who used hot biopsy
forceps/ablation and complex colonoscopy procedures; however, the use of cold biopsy and
snare polypectomy was associated with decreased polypectomy rates (Table 3). Cold biopsy
forceps and complex colonoscopy were procedures of choice for repeat endoscopy. Hot biopsy
forceps/ablation polypectomy was less likely used for repeat endoscopy (Table 3).

Table 3. Odds Ratios (95% Confidence Intervals) from Multivariate Logistic Regression
Analyses of Use of Polypectomy Procedures for Endoscopist Specialty and Volume Categories.†

Primary care
Surgery
Gastroenterology
Volume < 150
Volume 150 - 299
Volume > 300
Polypectomy rate
Repeat endoscopy

Cold biopsy forceps
(n=73,151)

Hot biopsy
forceps/Ablation
(n=98,486)

Snare polypectomy
(n=99,776)

Complex Colonoscopy
(n=52,172)

1.123 (1.086 - 1.161) ***
0.608 (0.585 - 0.632)***
1
1.100 (1.072 - 1.128)***
0.990 (0.970 - 1.011)
1
0.286 (0.269 - 0.305)***
1.175 (1.106 - 1.248)***

1.201 (1.166 - 1.237) ***
1.842 (1.791 - 1.896)***
1
1.158 (1.132 - 1.185)***
1.088 (1.068 -1.109)***
1
1.823 (1.729 - 1.922)***
0.761 (0.720 - 0.806)***

0.844 (0.818 - 0.870)***
0.690 (0.668 - 0.712)***
1
0.868 (0.848 - 0.888)***
0.972 (0.954 - 0.99)***
1
0.257 (0.244 - 0.272)***
0.991 (0.940 - 1.046)

0.827 (0.795 - 0.862)***
1.023 (0.983 - 1.065)
1
0.836 (0.812 - 0.861)***
0.898 (0.877 - 0.919)***
1
12.975 (12.145 - 13.862)***
1.235 (1.160 - 1.314)***

†All models statistically controlled for differences in facility type, patient demographic characteristics,
severity of illness, comorbidities, health insurance types, and the year of a procedure.
***: p<0.01

In a stratified multivariate analysis of cold biopsy forceps (Table 4), neither endoscopist
specialty types nor volume categories were statistically different from referent groups in terms of
the odds of adverse events. For hot forceps biopsy/ablation, the odds ratios of serious adverse
events were not statistically significantly different for endoscopist specialties; however, low(1.61 [95%CI, 1.16 to 2.24]) and medium-volume (1.43 [95%CI, 1.07 to 1.90]) endoscopists
reported higher odds of adverse events relative to high-volume providers. Similarly for snare
polypectomy, the endoscopist specialty did not contribute to increased odds of adverse events,
but high-volume providers had lower odds of adverse events. For complex colonoscopy, lowvolume providers (1.45 [95% CI, 1.05 to 2.01]) reported higher odds of adverse events relative to
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high-volume endoscopists Finally, higher odds of adverse events were reported for primary care
endoscopists (1.74 [95%CI, 1.18 to 2.56]) relative to gastroenterologists for complex
colonoscopy. There were no differences in odd ratios reported for surgeons in comparison with
gastroenterologists after complex colonoscopy. Neither polypectomy rate nor repeat endoscopy
was associated with increased odds of serious adverse events.
Table 4. Odds Ratios (95% Confidence Intervals) from Multivariate Logistic Regression Analyses of
Serious GI Adverse Events for Endoscopist Specialty and Volume Categories, Stratified by Polypectomy
Procedure.†
Cold biopsy forceps
(n=73,151)

Characteristics

Primary care
Surgeon
Gastroenterology
Volume < 150
Volume 150 - 299
Volume > 300
Polypectomy rate
Repeat Endoscopy

0.965 (0.457, 2.036)
1.526 (0.740, 3.146)
1
1.363 (0.774, 2.398)
1.143 (0.699, 1.870)
1
0.480 (0.111 - 2.087)
0.507 (0.070 - 3.651)

Hot biopsy
forceps/Ablation
(n=98,486)
0.847 (0.552, 1.299)
0.884 (0.605, 1.292)
1
1.607 (1.155, 2.237)***
1.429 (1.073, 1.903)**
1
1.512 (0.728 - 3.139)
0.494 (0.158 - 1.544)

Snare polypectomy
(n=99,776)
1.174 (0.829, 1.661)
1.041 (0.704, 1.540)
1
1.366 (1.025, 1.821)**
1.397 (1.112, 1.756)***
1
1.442 (0.707 - 2.942)
0.463 (0.192 - 1.121)

Complex Colonoscopy
(n=52,172)
1.740 (1.183, 2.559) ***
0.970 (0.607, 1.551)
1
1.450 (1.046, 2.009)**
0.852 (0.633, 1.146)
1
1.200 (0.564 - 2.556)
0.250 (0.062 - 1.006)

†All models statistically controlled for differences in facility type, patient demographic
characteristics, severity of illness, comorbidities, health insurance types, and the year of a
procedure.
***: p<0.01,**: p<0.05

Discussion
About half of all colonoscopy procedures are polypectomies [15]. Polypectomy is
important for CRC prevention, but is associated with adverse events. While adverse events after
polypectomy are rare, they are serious and life threatening [16]. The colonic perforation is the
most serious adverse event with reported rates of 0.1% - 0.3% and a fatality rate of 5% [16].
Gastrointestinal (GI) bleeding is the most common serious adverse event with reported risks of
0.1% - 0.6% [16]. Polypectomy was associated with up to a nine-fold increase[12-14] in risks of
serious adverse events when compared to a relatively safe diagnostic colonoscopy [16-17].
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Reported risks of adverse events increased, as the complexity of polypectomy procedures has
heightened [12]. Similarly to previous findings, this study’s reported rate of the colonic
perforations and GI bleeding is 0.4%. The current study also suggests that the complexity of
polypectomy procedures may contribute to increased risks of adverse events for endoscopists in
different specialty groups.
The current study is the first to investigate the use of specific polypectomy techniques for
primary care, surgery, and gastroenterology endoscopists, endoscopist volume categories, and to
identify associated odds ratios for serious GI adverse events. We also observed important trends
in the use of polypectomy techniques by endoscopist specialty and experience. Primary care
endoscopists and surgeons were more likely to use hot biopsy forceps/ablation for polyp or
lesion removal in comparison with gastroenterologists. In addition, gastroenterologists provided
more snare polypectomy and complex colonoscopy procedures than non-gastroenterologists.
The high-volume endoscopists were more likely to provide complex colonoscopies.
Polypectomy rates were higher for endoscopists who used hot biopsy forceps/ablation and
complex colonoscopy procedures. Cold biopsy forceps and complex colonoscopy were
procedures of choice for repeat endoscopy. It is expected that complex colonoscopy is used for
detection and removal of adenomas that vary in location, types, multiplicity, and size during the
initial and repeat endoscopy. Cold biopsy forceps are likely to be used in repeat endoscopy to
assure a complete adenoma removal. However, a use of hot biopsy forceps for initial endoscopy
require additional research as the experts recommended cold snare polypectomy instead of hot
biopsy forceps.
Our study found that endoscopists in all specialty and volume categories could safely use
cold biopsy forceps. These findings corroborate the literature suggesting that cold polypectomy
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techniques are the safest in terms of risks of serious GI adverse events [12,24]. More research is
warranted on cold polypectomy techniques and post-colonoscopy CRC, as some studies reported
that residual polyp tissues were discovered after cold forceps [25-26]. Our study also identified
that endoscopist volume, but not specialty, may be associated with reduced risks of serious GI
adverse events after hot biopsy forceps/ablation and snare polypectomy. On the other hand,
endoscopist specialty, but not volume, may contribute to reduction of the risks of serious adverse
events after complex colonoscopy, as higher odds of adverse events were reported for primary
care providers relative to the odds of adverse events reported for gastroenterologists and
surgeons. Patient outcomes were comparable for surgeons and gastroenterologists.
For primary and single procedures requiring either polypectomy via hot biopsy
forceps/ablation or snare polypectomy, an annual volume of 300 or more polypectomies was
important for reduction of serious adverse events. The European guidelines on colonoscopy
volume recommend a 300-volume threshold [27]. Our findings suggest that hot biopsy/ablation
or snare polypectomy techniques may be improved as endoscopists provide higher volumes of
these types of procedures. In terms of snare polypectomy, these findings may correspond well
with recommended by the American College of Gastroenterology practices of cold snare
techniques over electrocautery polypectomy [28]. However, additional research on the value of
polypectomy via hot biopsy forceps/ablation is needed specifically for non-gastroenterologists
who tend to use more of this type of polypectomy in comparison with gastroenterologists.
An endoscopist specialization in gastroenterology or surgery and annual polypectomy
volume greater than 150 procedures are important for reducing the rates of serious GI adverse
events after complex colonoscopy. Complex colonoscopy is effective for detecting polyps and is
often used for repeat endoscopy. Complex colonoscopy may involve a combination of several
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polypectomy techniques performed during the same session when multiple polyps or lesions of
various sizes and types are likely to be removed. Previous research suggested that primary care
physicians were less likely to use complex gastrointestinal procedures [5], and confirmed by our
findings. Differences in duration and intensity of training in endoscopy for primary care
endoscopists may explain this finding. As such, primary care endoscopists may require crosstraining and/or continuing medical education in complex colonoscopy techniques to prepare for
the growing demand of polypectomy due to the aging population in the U.S.
The study has limitations. We used historic data for the period 1999-2001. However, the
studied polypectomy techniques are still widely used by endoscopists, and a slow adoption of
new techniques, e.g. micro-clips, has been reported [14]. As such, our findings provide relevant
baseline data for the future research on the impact of endoscopist specialty and polypectomy
techniques on various patient outcomes. Although the study is population-based, it is restricted
to a single state. New research utilizing newer datasets from additional states is warranted. A
lack of access to patients’ medical records to fully adjust for the quality of bowel preparation or
prior use of medications (e.g., anticoagulants or antibiotics), especially by elderly patients, was a
limitation. In addition, data were not available to include adverse events associated with 30-day
ER visits and colonoscopies provided in physician offices. The study’s data did not distinguish
between GI bleeding potentially unrelated to polypectomy (e.g., bleeding from hemorrhoids,
diverticula, or due to radiation proctitis, or other entities. However, the serious GI adverse
events requiring inpatient admission were procedure specific and may have occurred due to
medical errors. The data did not capture the few patients with colonoscopy-related adverse
events who were hospitalized outside the state of Florida and those who were treated in
physician offices. It is unlikely that many polypectomy procedures would be carried out in

20

physician offices. The data did not include information on endoscopists’ age, years of practice,
affiliation with academic centers, and other experiences that may potentially affect the rate of
adverse events. There was also no information on lesion type, polyp size and multiplicity in the
dataset. As such, there may be potential confounding between polyp or lesion type/size, multiple
polyps, and choice of polyp removal technique. However, we used a validated risk adjustment
approach that accounted for both severity of current illness (e.g., a polyposis) and comorbidities.
More research utilizing newer datasets from additional states and clinical information is needed
to better understand which type of polypectomy, endoscopist specialty and experience, are
preferred for increasing adenoma detection rates, and reducing rates of adverse events and postcolonoscopy CRC. In addition, because change in endoscopy practices might require a
considerable amount of time, additional research on barriers for adoption of new practices, such
as awareness of and compliance with the colonoscopy guidelines across endoscopist specialties,
is important to consider.
Nevertheless, this research has several implications for clinical practice and policy. We
analyze all-encounter, all payer data covering the entire population of Florida for a three-year
period. This provides an important advancement over previous studies that examined a limited
number of facilities or health systems, used restricted datasets such as Medicare or Medicaid-only
data, or were non-US-based. Our database is unique as it reports UPINs for each endoscopists
allowing us to construct a measure of endoscopist specialty, and to report a use of polypectomy
procedures and rates of adverse events by endoscopist characteristics.

We believe our study is the first to report important variations in the use of polypectomy
techniques. We found that non-gastroenterologists and low-volume endoscopists tend to
perform simpler procedures than gastroenterologists. The risk of serious adverse events is small
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for cold biopsy forceps procedures and independent of endoscopist specialty and experience.
Thus, cold biopsy forceps is a safe procedure that may be widely used in clinical practice of
primary care endoscopists, surgeons, and gastroenterologists. A technical proficiency in hot
biopsy/ablation and snare polypectomy is achievable with experience (i.e., increased volume) for
endoscopist in all specialty categories. Providing more than 300 polypectomy procedures
annually may be an important benchmark for improving endoscopists experience and achieving
proficiency in polypectomy. Surgeons, gastroenterologists, and higher-volume providers had
lower rates of adverse events than primary care and low-volume endoscopists (i.e., providing
less than 150 procedures annually) for complex colonoscopy. As such, some cross-training and
continuing medical education in complex polypectomy techniques for primary care endoscopists
in high-volume settings may be considered.
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